Strategic Initiatives and Refined Business Model Produced Financial and Operating Efficiencies Established Long-Term License and Supply Agreement to Commercialize VAZKEPA® Across Europe and Sustained ...

A 76-year-old experiences shortness of breath and tachycardia after coronary artery bypass surgery. What does the ECG reveal?

What should you do if your wearable device tells you something’s amiss, but you feel fine? Believe the tech and get yourself ...

1 Department of Cardiology, Yan’an Hospital, Kunming Medical University, Kunming, China 2 Ultrasound Department, Kunming Maternal and Child Health Hospital, Kunming, China, kunming, China The final, ...

Inside the human chest, a tireless engine performs a rhythmic masterpiece roughly one hundred thousand times a day. If you ...

Cavotricuspid isthmus (CTI) ablation with a linear pulsed field ablation (PFA) catheter was associated with safety and efficacy similar to radiofrequency ablation (RFA) and greater efficiency in ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, where new clinical data ...

Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow BOSTON--(BUSINESS WIRE)--#AFSymposium2026--Vektor ...

BOSTON--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, ...

Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...

This population-based nested case-control study analyzed data from the Korean National Health Insurance Corporation (2002–2019). Adults aged ≥19 years with at least three years of recorded claims were ...

The competing risk of nonstroke mortality may limit the potential benefit of stroke prophylaxis therapy in patients with atrial fibrillation or atrial flutter AF. Among a total of 1 883 759 Medicare ...